cigna glp 1 program is ending employee coverage for GLP-1 weight-loss drugs like Wegovy and Zepbound starting July 1. The decision highlights growing debates around cost, access, and the future of obesity treatment. #Cigna #GLP1 # Cigna CEO on medicare advantage
Description
But these drugs have a much longer history
This shouldnt be for cosmetic weight loss
Yes, headaches are a recognized side effect of GLP-1 medications
But wed rather offer something that works than sell convenience that doesnt deliver
It's important to note that getting a Wegovy or Ozempic (semaglutide) prescription online without proper advice from your doctor can pose risks
A compounded vial is a different preparation made by a pharmacy, and it is not FDA-approved, so the FDA has not reviewed its quality or stability
